These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7646476

  • 21. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?
    Han H, Weinreb PH, Lansbury PT.
    Chem Biol; 1995 Mar; 2(3):163-9. PubMed ID: 9383418
    [Abstract] [Full Text] [Related]

  • 22. Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking.
    Wilhelmus MMM, Jongenelen CA, Bol JGJM, Drukarch B.
    Anal Biochem; 2020 Mar 01; 592():113578. PubMed ID: 31923381
    [Abstract] [Full Text] [Related]

  • 23. The synuclein family.
    Lavedan C.
    Genome Res; 1998 Sep 01; 8(9):871-80. PubMed ID: 9750188
    [Abstract] [Full Text] [Related]

  • 24. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
    Windisch M, Hutter-Paier B, Schreiner E, Wronski R.
    J Mol Neurosci; 2004 Sep 01; 24(1):155-65. PubMed ID: 15314265
    [Abstract] [Full Text] [Related]

  • 25. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
    Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5462-6. PubMed ID: 1608956
    [Abstract] [Full Text] [Related]

  • 26. Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases.
    Sung JY, Park SM, Lee CH, Um JW, Lee HJ, Kim J, Oh YJ, Lee ST, Paik SR, Chung KC.
    J Biol Chem; 2005 Jul 01; 280(26):25216-24. PubMed ID: 15863497
    [Abstract] [Full Text] [Related]

  • 27. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M, Drukarch B, Hofstee M, Brevé J, Jongenelen CA, Bol JG, Wilhelmus MM.
    J Neurochem; 2015 Sep 01; 134(6):1116-28. PubMed ID: 26088696
    [Abstract] [Full Text] [Related]

  • 28. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M, Rockenstein E, Crews L, Masliah E.
    Neuromolecular Med; 2003 Sep 01; 4(1-2):21-36. PubMed ID: 14528050
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding.
    Liu LL, Franz KJ.
    J Am Chem Soc; 2005 Jul 13; 127(27):9662-3. PubMed ID: 15998051
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM, Irvine GB.
    J Struct Biol; 2000 Jun 13; 130(2-3):300-9. PubMed ID: 10940234
    [Abstract] [Full Text] [Related]

  • 36. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM, Paleologou KE, Greer B, Abogrein AM, King JE, Salem SA, Fullwood NJ, Benson FE, Hewitt R, Ford KJ, Martin FL, Harriott P, Cookson MR, Allsop D.
    FASEB J; 2004 Aug 13; 18(11):1315-7. PubMed ID: 15180968
    [Abstract] [Full Text] [Related]

  • 37. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM, Schulz P, Sierks MR.
    Eur J Neurosci; 2016 Jan 13; 43(1):3-16. PubMed ID: 26332448
    [Abstract] [Full Text] [Related]

  • 38. Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.
    Sode K, Usuzaka E, Kobayashi N, Ochiai S.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):432-6. PubMed ID: 16081040
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques.
    Zhang W, Johnson BR, Suri DE, Martinez J, Bjornsson TD.
    Acta Neuropathol; 1998 Oct 23; 96(4):395-400. PubMed ID: 9797004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.